Friday, March 13, 2009

Repoxygen- the future of doping Part 2

There are some reports that a few European athletes may have injected themselves with this gene (or related product) to increase their red blood cell mass.

However, physiologically, if a person has a normal red cell count and normal oxygen concentration, the gene would not activate the release of EPO. The gene is only programmed to activate when it senses low oxygen. While there is some who say this is a poor choice for doping, the problem can easily be circumvented by tricking the gene.

There are some simple ways to make the gene sense low oxygen in the body. This is by working out in cold weather or taking pills of nitroglycerin or sodium thiocyanate. Nitroglycerin is a common drug used to treat patients who have angina.

However, this self regulation of the gene is simply a hypothetical concept and not proven in the laboratory or in any patient. As far as is known, injection of the gene will stimulate the production of EPO forever. Once the gene is inserted into the body, it is there for life.

No comments:

Post a Comment